chemical · input

Neonicotinoid Active Ingredients (Imidacloprid / Thiamethoxam)

Systemic insecticides; Bayer dominant in imidacloprid (launched 1991), Syngenta in thiamethoxam; EU outdoor bans create bifurcated global market.

5

Source countries

7

Companies

1

Goods affected

0

Claims on record

What depends on it

Goods that need this input

1 essential American goods rely on neonicotinoid active ingredients (imidacloprid / thiamethoxam) somewhere upstream in their supply chain.

Where it comes from

Source countries

Share of global supply, by country.

CountryShare of supply
CNChina52%
DEGermany20%
JPJapan14%
GBUnited Kingdom9%
INIndia5%

Who makes it

Supplier companies

7 companies produce neonicotinoid active ingredients (imidacloprid / thiamethoxam).

Bayer AG

HQ DE35% share

Pharma and crop science giant; acquired Monsanto 2018; largest glyphosate and imidacloprid branded seller globally.

Bayer Crop Science(BAYN)

HQ DE28% share

Bayer AG Crop Science division (Monheim am Rhein, Germany; XETRA: BAYN; ~€23B Crop Science revenue 2023) invented imidacloprid in 1985 and co-developed clothianidin with Nippon Soda (licensed from Takeda Chemical). Imidacloprid is the best-selling insecticide in the world by value (~$1.1B annual sales) across foliar, soil-drench, trunk-injection, and aquatic-herbicide use patterns — including structural pest control (termite soil treatments, whitefly foliar sprays on vegetables) and vector control programs (mosquito/bed bug treatments in public health applications). Bayer manufactures imidacloprid and clothianidin technical grade at Dormagen and Leverkusen (North Rhine-Westphalia) and at Monheim R&D/production. Post-2018 EU outdoor ban, Bayer pivoted residual imidacloprid volume toward non-EU foliar markets (India, Brazil, US, Southeast Asia) and veterinary/companion animal applications (Seresto collar — transferred to Elanco 2020).

Syngenta Group

HQ CH25% share

Agrochemical major (ChemChina/Sinochem owned); atrazine, thiamethoxam, and fungicide market leader; 39.88% stake in Yangnong Chemical.

Syngenta Group (ChemChina)

HQ CH22% share

Syngenta Group (Basel, Switzerland; wholly owned by ChemChina / Sinochem Holdings since 2017 at $43B — the largest Chinese acquisition of a foreign company at the time) invented thiamethoxam (Actara foliar/soil insecticide; Cruiser seed treatment) and is the primary global producer. Actara and Engeo Pleno (lambda-cyhalothrin + thiamethoxam) are the leading foliar neonicotinoid products for whitefly, leafhopper, and aphid control on vegetables, citrus, and cotton globally. Syngenta also produces acetamiprid (Assail) for foliar use. Manufacturing at Huddersfield UK (primary thiamethoxam) and Schweizerhalle/Basel Switzerland. ChemChina's 2021 merger with Sinochem created a combined entity (~$150B revenue) that includes ADAMA generic agrochemicals — giving a single Chinese state-linked conglomerate both the branded thiamethoxam franchise and significant generic neonicotinoid capacity.

Jiangsu Yangnong Chemical Group

HQ CN18% share

Jiangsu Yangnong Chemical Group Co., Ltd. (Yangzhou, Jiangsu Province, China; SSE: 600486; ~¥8B revenue) is the largest identified Chinese generic producer of imidacloprid and a major manufacturer of acetamiprid and thiamethoxam technical grade. After Bayer's imidacloprid patents expired, Yangnong built large-scale generic capacity at its Yangzhou Jiangsu complex — producing technical grade AI for export to Asia, Africa, Latin America, and re-export through European and US formulators. China as a whole (including Yangnong, Shandong Sino-Agri United Biotechnology, Yancheng Limin Chemical, and 15-20 smaller producers) accounts for an estimated 50-60% of global neonicotinoid active ingredient by volume. Yangnong alone represents approximately 15-20% of global imidacloprid volume. Chinese generic neonicotinoids undercut originator prices by 60-80%, dominating developing-country markets and penetrating US generic supply chains.

Sumitomo Chemical Co., Ltd.

HQ JP10% share

Sumitomo Chemical Co. Ltd. (Tokyo Japan; TYO: 4005; Sumitomo Group); #3 global DL-methionine producer at ~13% market share via Niihama Ehime Works (Ehime Prefecture Shikoku Japan). After a major expansion completed October 2018 (+100,000 MT/year new line), the Niihama facility reached ~250,000 MT/year — one of the world's largest single methionine plants. Also produces crop protection chemicals (agrichemicals), petrochemicals, and pharmaceuticals. The MetiPEARL / liquid methionine brand competes directly with Evonik MetAMINO and Adisseo Rhodimet in Asian poultry markets. Japan is the only significant Japanese methionine production base globally.

Nippon Soda Co.

HQ JP8% share

Nippon Soda Co., Ltd. (Tokyo; TSE: 4041; ~¥140B revenue) is the patent originator of acetamiprid (Mospilan) and a co-developer of clothianidin (with Bayer and Takeda). Acetamiprid is the only first-generation neonicotinoid not subject to the EU's 2018 outdoor ban, positioning Nippon Soda advantageously as the EU market shifts to permitted alternatives. Nippon Soda manufactures acetamiprid technical grade at the Nihongi Plant (Niigata Prefecture) and licenses production globally. Acetamiprid is used extensively in foliar applications on vegetables, fruit, and tea (particularly in Japan), and is approved for more uses in the EU than any other neonicotinoid. Nippon Soda licenses acetamiprid to Sumitomo Chemical, Nufarm, and multiple generic producers under branded and OEM agreements.